Today: 21 May 2026
XRP price forecast 2026: Standard Chartered’s $8 call meets a $1.87 market as ETF flows stay in focus
1 January 2026
1 min read

XRP price forecast 2026: Standard Chartered’s $8 call meets a $1.87 market as ETF flows stay in focus

NEW YORK, January 1, 2026, 15:31 ET

  • XRP was up about 2.7% at $1.87, while bitcoin and ether also rose, according to market data.
  • Standard Chartered’s Geoffrey Kendrick projected XRP could reach $8 by the end of 2026, FXEmpire reported.
  • SoSoValue data cited by FXEmpire showed U.S. spot XRP ETFs have stayed net positive since launching in mid-November, lifting total net inflows to about $1.16 billion.

Standard Chartered’s projection that XRP could reach $8 by the end of 2026 has returned to the center of crypto market debate as the token traded around $1.87 on Thursday.

The forecast matters now because the route many institutions use to buy crypto is changing. Spot exchange-traded funds (ETFs) — listed products designed to track an asset — are giving investors a regulated way to gain exposure to tokens such as XRP.

That shift is forcing traders to weigh longer-dated price targets against near-term liquidity and positioning as 2026 begins.

XRP was last up about 2.7% at $1.87, while bitcoin rose about 1.0% to $88,236 and ether gained about 0.7% to $2,987.93, according to market data.

FXEmpire reported that Geoffrey Kendrick, Standard Chartered’s global head of digital assets research, projected a year-end 2026 XRP price of $8. Kendrick also outlined a $12.5 target for 2028, the report said.

The FXEmpire report said Kendrick’s thesis leaned on legal clarity after the Ripple-SEC settlement and on institutional adoption through XRP ETFs.

SoSoValue data cited by FXEmpire showed the U.S. spot XRP ETF market took in $15.55 million on Dec. 30 and has not recorded an outflow since launching in mid-November, lifting total net inflows to about $1.16 billion.

FXEmpire also pointed to U.S. spot bitcoin ETFs posting net outflows of about $2.74 billion since Nov. 14, feeding talk that XRP could “decouple” — trade on its own rather than move in lockstep with bitcoin. FXEmpire

“XRP … is going to be a divergent asset,” Canary Funds CEO Steven McClurg said in a Token Relations broadcast cited by FXEmpire. FXEmpire

Derivatives positioning has also climbed, even as the spot price has not broken out. TradingView reported outstanding XRP derivatives contracts at about 1.74 billion XRP, roughly $3.26 billion in futures exposure — a rise in open interest, meaning the value of outstanding futures bets.

XRP is the native token of the XRP Ledger, a blockchain designed for payments, and Ripple uses XRP as a bridge asset in some cross-border transfers, Reuters Practical Law reported. Ripple also created an escrow structure to manage the release of a large pool of XRP over time.

The SEC sued Ripple in 2020, alleging XRP sales were unregistered securities; a U.S. judge later ruled exchange-traded XRP sales were not securities transactions while certain institutional sales were, and the case later moved toward resolution, Reuters Practical Law reported.

For now, the market’s near-term test remains whether XRP can clear the psychologically important $2 level and whether ETF inflows remain steady. FXEmpire cited technical resistance near $2, while TradingView flagged heavier derivatives activity without a comparable price surge.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
ASX 200 forecast for 2026: Rate-hike bets return as strategists split on Australia stocks
Previous Story

ASX 200 forecast for 2026: Rate-hike bets return as strategists split on Australia stocks

Microsoft stock forecast for 2026: Wedbush puts $625 target on MSFT as “inflection year” looms
Next Story

Microsoft stock forecast for 2026: Wedbush puts $625 target on MSFT as “inflection year” looms

Go toTop